TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor Family member with regulatory functions in inflammation and immunity

Frontiers in Immunology

Volumn 3, Issue OCT, 2012, Pages

  Riva, Federica ^a   Bonavita, Eduardo ^b   Barbati, Elisa ^a,b   Muzio, Marta ^c   Mantovani, Alberto ^a,b   Garlanda, Cecilia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cytokine; Infection; Inflammation; Inflammation associated cancer; Interleukin 1; Toll like receptors

Indexed keywords

EID: 84874217124     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00322     Document Type: Review

References (105)

1. Abdollahi-Roodsaz, S., Joosten, L. A., Koenders, M. I., Van Den Brand, B. T., Van De Loo, F. A., and Van Den Berg, W. B. (2009). Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am. J. Pathol. 175, 2004-2013.
2. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., and Sallusto, F. (2007). Interleukins 1beta and 6 but not transforming growthfactor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942-949.
3. Adib-Conquy, M., Adrie, C., Fitting, C., Gattolliat, O., Beyaert, R., and Cavaillon, J. M. (2006). Up-regulation of MyD88s and SIGIRR, molecules inhibiting toll-like receptor signaling, in monocytes from septic patients. Crit. Care Med. 34, 2377-2385.
4. Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., Van Royen-Kerkhoff, A., et al. (2009). An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 360, 2426-2437.
5. Andre, R., Lerouet, D., Kimber, I., Pin-teaux, E., and Rothwell, N. J. (2005). Regulationof expression of the novel IL-1 receptor family members in the mouse brain. J. Neurochem. 95, 324-330.
6. Aoki, K., Tamai, Y., Horiike, S., Oshima, M., and Taketo, M. M. (2003). Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+(-compound mutant mice. Nat. Genet. 35, 323-330.
7. Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., et al. (2005). MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23.
8. Arvaniti, E., Ntoufa, S., Papakon-stantinou, N., Touloumenidou, T., Laoutaris, N., Anagnostopoulos, A., et al. (2011). Toll-like receptor signaling pathway in chronic lympho-cytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica 96, 1644-1652.
9. Batliwalla, F. M., Li, W., Ritchlin, C. T., Xiao, X., Brenner, M., Laragione, T., et al. (2005). Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol. Med. 11, 21-29.
10. Bazzoni, F., Rossato, M., Fabbri, M., Gaudiosi, D., Mirolo, M., Mori, L., et al. (2009). Induction and regulatory function of miR-9 in human mono-cytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. U.S.A. 106, 5282-5287.
11. Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-kappaBasthe matchmaker.Nat. Immunol. 12, 715-723.
12. Bertilaccio, M. T., Simonetti, G., Dagk-lis, A., Rocchi, M., Rodriguez, T. V., Apollonio, B., et al. (2011). Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 118, 660-669.
13. Bichi, R., Shinton, S. A., Martin, E. S., Koval, A., Calin, G. A., Cesari, R., et al. (2002). Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl. Acad. Sci. U.S.A. 99, 6955-6960.
14. Biswas, S. K., and Mantovani,A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
15. Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., et al. (2011). IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur. Cytokine Netw. 22, 127-147.
16. Bozza, S., Zelante, T., Moretti, S., Boni-fazi, P., Deluca, A., D'angelo, C., et al. (2008). Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180, 4022-4031.
17. Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M. F., Herjan, T., et al. (2009). The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulationof Th2 immune response. J. Immunol. 182, 2601-2609.
18. Cavassani, K. A., Ishii, M., Wen, H., Schaller, M. A., Lincoln, P. M., Lukacs, N. W., et al. (2008). TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609-2621.
19. Chan, W. L., Pejnovic, N., Lee, C. A., and Al-Ali, N. A. (2001). Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes. J. Immunol. 167, 1238-1244.
20. Chen, X., Zhao, Y., Wu, X., and Qian, G. (2011). Enhanced expression of single immunoglobulin IL-1 receptor-related molecule ameliorates LPS-induced acute lung injury in mice. Shock 35, 198-204.
21. Cherfils-Vicini, J., Platonova, S., Gillard, M., Laurans, L., Validire, P., Calian-dro, R., et al. (2010). Triggering of TLR7 and TLR8 expressedbyhuman lung cancer cells induces cell survival and chemoresistance. J. Clin. Invest. 120, 1285-1297.
22. Chowdhury, P., Sacks, S. H., and Sheerin, N. S. (2010). Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephron Exp. Nephrol. 115, e122-e130.
23. Colotta, F., Allavena, P., Sica, A., Gar-landa, C., and Mantovani,A. (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081.
24. Costello, D. A., Watson, M. B., Cow-ley, T. R., Murphy, N., Murphy Royal, C., Garlanda, C., et al. (2011). Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. J. Neurosci. 31, 3871-3879.
25. Costelloe, C., Watson, M., Murphy, A., Mcquillan, K., Loscher, C., Armstrong, M. E., et al. (2008). IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J. Neurochem. 105, 1960-1969.
26. Davies, J. M., Macsharry, J., and Shana-han, F. (2010). Differential regulation of toll-like receptor signalling in spleen and Peyer's patch dendritic cells. Immunology 131, 438-448.
27. Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., et al. (2010). IL-1 family nomenclature. Nat. Immunol. 11, 973.
28. Dinarello, C. A. (2000). The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343, 732-734.
29. Dinarello, C. A. (2009). Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550.
30. Drexler, S. K., and Foxwell, B. M. (2010). The role of toll-like receptors in chronic inflammation. Int. J. Biochem. Cell Biol. 42, 506-518.
31. Drexler, S. K., Kong, P., Inglis, J., Williams, R. O., Garlanda, C., Man-tovani,A.,et al. (2010). SIGIRR/TIR-8 is an inhibitor of toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis Rheum. 62, 2249-2261.
32. Garlanda, C., Anders, H. J., and Manto-vani,A. (2009). TIR8/SIGIRR:anIL-1R/TLR family member with regulatory functions in inflammation and T cell polarization. Trends Immunol. 30, 439-446.
33. Garlanda, C., Di Liberto, D., Vecchi, A., La Manna, M. P., Buracchi, C., Cac-camo, N., et al. (2007a). Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J. Immunol. 179, 3119-3125.
34. Garlanda, C., Riva, F., Veliz, T., Polen-tarutti, N., Pasqualini, F., and Radaelli, E. (2007b). Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67, 6017-6021.
35. Garlanda, C., Riva, F., Polentarutti, N., Buracchi,C.,Sironi, M.,and DeBor-toli, M. (2004). Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. U.S.A. 101, 3522-3526.
36. Gay, N. J., Gangloff, M., and O'Neill, L. A. (2011). What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 32, 104-109.
37. Ghia, P., and Caligaris-Cappio, F. (2006). The origin of B-cell chronic lymphocytic leukemia. Semin. Oncol. 33, 150-156.
38. Gong, J., Wei, T., Stark, R. W., Jamitzky, F., Heckl, W. M., Anders, H. J., et al. (2010). Inhibition of tolllike receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J. Struct. Biol. 169, 323-330.
39. Gopal, R., Birdsell, D., and Monroy, F. P. (2008). Regulation of toll-like receptors in intestinal epithelial cells by stress and Toxoplasma gondii infection. Parasite Immunol. 30, 563-576.
40. Gu, Y. F., Fang, Y., Jin, Y., Dong, W. R., Xiang, L. X., and Shao, J. Z. (2011). Discovery of the DIGIRR gene from teleost fish: a novel toll-IL-1 receptor family member serving as a negative regulator of IL-1 signaling. J. Immunol. 187, 2514-2530.
41. Gulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., et al. (2010). The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32, 54-66.
42. Horne, D. J., Randhawa, A. K., Chau, T. T., Bang, N. D., Yen, N. T., Farrar, J. J., et al. (2012). Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J. Infect. Dis. 205, 586-594.
43. Huang, X., Hazlett, L. D., Du, W., and Barrett, R. P. (2006). SIGIRR promotes resistance against Pseudomonas aeruginosa ker-atitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J. Immunol. 177, 548-556.
44. Janssens, S., Burns, K., Vercammen, E., Tschopp, J., and Beyaert, R. (2003). MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB-and AP-1-dependent gene expression. FEBS Lett. 548, 103-107.
45. Jiang, X., Mcclellan, S. A., Barrett, R. P., Zhang, Y., and Hazlett, L. D. (2012). Vasoactive intestinal peptide downregulates proin-flammatory TLRs while upregulat-ing anti-inflammatory TLRs in the infected cornea. J. Immunol. 189, 269-278.
46. Kadota, C., Ishihara, S., Aziz, M. M., Rumi, M. A., Oshima, N., Mishima, Y., et al. (2010). Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cellsduring inflammation.Clin. Exp. Immunol. 162, 348-361.
47. Kang, J. Y., and Lee, J. O. (2011). Structural biology of the toll-like receptor family. Annu. Rev. Biochem. 80, 917-941.
48. Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-436.
49. Karin, M., Lawrence, T., and Nizet, V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823-835.
50. Khan, M. A., Steiner, T. S., Sham, H. P., Bergstrom, K. S., Huang, J. T., Assi, K., et al. (2010). The single IgG IL-1-related receptor controls TLR responses in differentiated human intestinal epithelial cells. J. Immunol. 184, 2305-2313.
51. Kobayashi, K., Hernandez, L. D., Galan, J. E., Janeway, C. A. Jr., Medzhi-tov, R., and Flavell, R. A. (2002). IRAK-M is a negative regulator of toll-like receptor signaling. Cell 110, 191-202.
52. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 416, 603-607.
53. Lech, M., Avila-Ferrufino, A., Allam, R., Segerer, S., Khandoga, A., Krom-bach, F., et al. (2009). Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J. Immunol. 183, 4109-4118.
54. Lech, M., Garlanda, C., Mantovani, A., Kirschning, C. J., Schlondorff, D., and Anders, H. J. (2007). Different roles of TiR8/Sigirr on tolllike receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int. 72, 182-192.
55. Lech, M., Kulkarni, O. P., Pfeiffer, S., Savarese, E., Krug, A., Garlanda, C., et al. (2008). Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J. Exp. Med. 205, 1879-1888.
56. Lech, M., Skuginna, V., Kulkarni, O. P., Gong, J., Wei, T., Stark, R. W., et al. (2010). Lack of SIGIRR/TIR8 aggra-vateshydrocarbonoil-induced lupus nephritis. J. Pathol. 220, 596-607.
57. Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J., Kirschning, C. J., et al. (2005). Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894-2903.
58. Li, X., and Qin, J. (2005). Modulation of toll-interleukin 1 receptor mediated signaling. J. Mol. Med. 83, 258-266.
59. Liang, X., Moseman,E.A., Farrar,M.A., Bachanova,V., Weisdorf,D.J., Blazar, B. R., et al. (2010). Toll-like receptor 9 signaling by CpG-B oligodeoxynu-cleotides induces an apoptotic pathway in human chronic lympho-cytic leukemia B cells. Blood 115, 5041-5052.
60. Lloyd, C. M. (2010). IL-33 family members and asthma - bridging innate and adaptive immune responses. Curr. Opin. Immunol. 22, 800-806.
61. Loiarro, M., Sette, C., Gallo, G., Ciacci, A., Fanto, N., Mastroianni, D., et al. (2005). Peptide-mediated interference of TIR domain dimeriza-tion in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B. J. Biol. Chem. 280, 15809-15814.
62. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
63. Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., and Allavena, P. (2001). Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22, 328-336.
64. Marshak-Rothstein, A., and Rifkin, I. R. (2007). Immunologically active autoantigens: the role of tolllike receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25, 419-441.
65. Mills, K. H. (2011). TLR-dependent T cell activation inautoimmunity.Nat. Rev. Immunol. 11, 807-822.
66. Muzio, M., Bertilaccio, M. T., Simon-etti, G.,Frenquelli, M.,and Caligaris-Cappio, F. (2009a). The role of toll-like receptors in chronic B-cell malignancies. Leuk. Lymphoma 50, 1573-1580.
67. Muzio, M., Scielzo, C., Bertilaccio, M. T., Frenquelli, M., Ghia, P., and Caligaris-Cappio, F. (2009b). Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br. J. Haematol. 144, 507-516.
68. Nahid,M.A., Satoh, M., and Chan,E.K. (2011). MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8, 388-403.
69. Nakashima, K., Hirota, T., Obara, K., Shimizu, M., Jodo, A., Kameda, M., et al. (2006). An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway.J. Hum. Genet.51,284-291.
70. Nanthakumar, N., Meng, D., Goldstein, A. M., Zhu, W., Lu, L., Uauy, R., et al. (2011). The mechanism of excessive intestinal inflammation in necrotizing enterocoli-tis: an immature innate immune response. PLoS ONE 6, e17776. doi:10.1371/journal.pone.0017776
71. Neighbors, M., Xu, X., Barrat, F. J., Ruuls, S. R., Churakova, T., Debets, R., et al. (2001). A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J. Exp. Med. 194, 343-354.
72. Noris, M., Cassis, P., Azzollini, N., Cav-inato, R., Cugini, D., Casiraghi, F., et al. (2009). The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J. Immunol. 183, 4249-4260.
73. Nunez Miguel, R., Wong, J., Westoll, J. F., Brooks, H. J., O'Neill, L. A., Gay, N. J., et al. (2007). A dimer of the toll-like receptor 4 cytoplas-mic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE 2, e788. doi:10.1371/journal.pone.0000788
74. O'Neill, L. A. (2006). How toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9.
75. O'Neill, L. A. (2008). The interleukin-1 receptor/toll-like receptor super-family: 10 years of progress. Immunol. Rev. 226, 10-18.
76. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., et al. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141.
77. Polentarutti, N., Rol, G. P., Muzio, M., Bosisio, D., Camnasio, M., Riva, F., et al. (2003). Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur. Cytokine Netw. 14, 211-218.
78. Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordonez, G. R., Vil-lamor, N., et al. (2011). Whole-genome sequencing identifies recurrent mutations in chronic lym-phocytic leukaemia. Nature 475, 101-105.
79. Qin, J., Qian, Y., Yao, J., Grace, C., and Li, X. (2005). SIGIRR inhibits interleukin-1 receptor-and tolllike receptor 4-mediated signaling through different mechanisms. J. Biol. Chem. 280, 25233-25241.
80. Quinn, S. R., and O'Neill, L. A. (2011). A trio of microRNAs that control toll-like receptor signalling. Int. Immunol. 23, 421-425.
81. Ragnarsdottir, B., Samuelsson, M., Gustafsson, M. C., Leijonhufvud, I., Karpman, D., and Svanborg, C. (2007). Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J. Infect. Dis. 196, 475-484.
82. Rakoff-Nahoum, S., and Medzhitov, R. (2009). Toll-like receptors and cancer. Nat. Rev. Cancer 9, 57-63.
83. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
84. Reddy, S., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., et al. (2009). An autoinflammatory disease due to homozygous deletion of theIL1RNlocus.N.Engl.J.Med.360, 2438-2444.
85. Riva, F., Polentarutti, N., Tribbioli, G., Mantovani, A., Garlanda, C., and Turin, L. (2009). The expression pattern of TIR8 is conserved among vertebrates. Vet. Immunol. Immunopathol. 131, 44-49.
86. Rossi, D., Rasi, S., Fabbri, G., Spina, V., Fangazio, M., Forconi, F., et al. (2012). Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119, 521-529.
87. Sacre, S. M., Andreakos, E., Kiri-akidis, S., Amjadi, P., Lundberg, A., Giddins, G., et al. (2007). The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am. J. Pathol. 170, 518-525.
88. Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R. M., et al. (2010). MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625-1636.
89. Sanchez, E., Garcia-Bermudez, M., Jimenez-Alonso, J., De Ramon, E., Sanchez-Roman, J., Ortego-Centeno, N., et al. (2012). Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population. Lupus 21, 1166-1171.
90. Savarese, E., Steinberg, C., Pawar, R. D., Reindl, W., Akira, S., Anders, H. J., et al. (2008). Requirement of toll-like receptor 7 for pristane-induced production of autoanti-bodies and development of murine lupus nephritis. Arthritis Rheum. 58, 1107-1115.
91. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., Mcclanahan, T. K., et al. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490.
92. Skuginna, V., Lech, M., Allam, R., Ryu, M., Clauss, S., Susanti, H. E., et al. (2011). Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. PLoS ONE 6, e19204. doi:10.1371/journal.pone.0019204
93. Tarnani, M., Laurenti, L., Longo, P. G., Piccirillo, N., Gobessi, S., Man-nocci, A., et al. (2010). The pro-liferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lym-phocytic leukemia. Leuk. Res. 34, 1189-1194.
94. Thomassen, E., Renshaw, B. R., and Sims, J. E. (1999). Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11, 389-399.
95. Towne,J. E., Garka,K.E.,Renshaw,B.R., Virca, G. D., and Sims, J. E. (2004). Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279, 13677-13688.
96. Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., and Hooper, L. V. (2008). Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U.S.A. 105, 20858-20863.
97. Van De Veerdonk, F. L., Netea, M. G., Dinarello, C. A., and Joosten, L. A. (2011). Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 32, 110-116.
98. Veliz Rodriguez, T., Moalli, F., Polen-tarutti, N., Paroni, M., Bonavita, E., Anselmo, A., et al. (2012). Role of toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection. Infect. Immun. 80, 100-109.
99. Villena, J., Suzuki, R., Fujie, H., Chiba, E., Takahashi, T., Tomosada, Y., et al. (2012). Immunobiotic Lacto-bacillus jensenii modulates the tolllike receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells. Clin. Vaccine Immunol. 19, 1038-1053.
100. Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., et al. (2003). SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4, 920-927.
101. Watson, M. B., Costello, D. A., Carney, D. G., Mcquillan, K., and Lynch, M.A. (2010). SIGIRR modulates the inflammatory response in the brain. Brain Behav. Immun. 24, 985-995.
102. Xiao, H., Gulen, M. F., Qin, J., Yao, J., Bulek, K., Kish, D., et al. (2007). The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461-475.
103. Xiao, H., Yin, W., Khan, M. A., Gulen, M. F., Zhou, H., Sham, H. P., et al. (2010). Loss of single immunoglob-ulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice. Gas-troenterology 139, 574-585.
104. Yamada, Y., Hata, K., Hirose, Y., Hara, A., Sugie, S., Kuno, T., et al. (2002). Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Cancer Res. 62, 6367-6370.
105. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., et al. (2007). IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37, 2695-2706.